The key equity indices came off the day's high in mid afternoon trade. The Nifty was trading above the 17,050 mark. FMCG shares extended gains for the third session.
At 14:26 IST, the barometer index, the S&P BSE Sensex, was up 386.60 points or 0.68% to 57,317.16. The Nifty 50 index gained 111.35 points or 0.66% to 17,066.80.
Sentiment got a boost as global shares were trading higher. Investors reacted to a study out of South Africa suggesting a reduced risk of hospitalization and severe disease with omicron compared to delta. Meanwhile, the U.S. Centers for Disease Control and Prevention authorized an antiviral Covid pill from Pfizer for people aged 12 and above at risk of severe illness.
In the broader market, the S&P BSE Mid-Cap index rose 0.89% while the S&P BSE Small-Cap index added 0.76%.
The market breadth was strong. On the BSE, 2215 shares rose and 1064 shares fell. A total of 132 shares were unchanged.
Numbers to Track:
The yield on 10-year benchmark federal paper was currently flat at 6.464%.
In the foreign exchange market, the rupee edged higher against the dollar. The partially convertible rupee was hovering at 75.2500, compared with its close of 75.5400 during the previous trading session.
MCX Gold futures for 4 February 2022 settlement added 0.06% to Rs 48,230.
In the commodities market, Brent crude for February 2022 settlement lost 30 cents or 0.40% to $74.99 a barrel.
Buzzing Index:
The Nifty FMCG index rose 1.03% to 36,881.35, extending gains for third consecutive session. The index has advanced 2.21% in three sessions.
Radico Khaitan (up 4.80%), ITC (up 2.55%), Marico (up 1.17%), Britannia Industries (up 1.15%), Colgate-Palmolive India (up 0.98%) and Hindustan Unilever (up 0.61%) advanced.
Global Markets:
Shares in Europe and Asia advanced on Thursday, as traders looked to signs that the omicron coronavirus variant is not as severe as previously feared.
The media reported that the Chinese city of Xi'an ordered its 13 million residents to stay at home as it deals with rising Covid cases.
U.S. stocks rose on Wednesday, rallying for a second day as the market continued to rebound from a three-day losing streak spurred by fears about the omicron variant.
US economic growth slowed in the third quarter amid a flare-up in COVID-19 infections, the government confirmed on Wednesday. Gross domestic product increased at a 2.3% annualised rate, the Commerce Department said in its third reading of GDP growth for the July-September quarter.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
